Advanced SearchSearch Tips
c-Jun N-terminal Kinase (JNK) induces phosphorylation of amyloid precursor protein (APP) at Thr668, in okadaic acid-induced neurodegeneration
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
  • Journal title : BMB Reports
  • Volume 49, Issue 7,  2016, pp.376-381
  • Publisher : Korean Society for Biochemistry and Molecular Biology
  • DOI : 10.5483/BMBRep.2016.49.7.246
 Title & Authors
c-Jun N-terminal Kinase (JNK) induces phosphorylation of amyloid precursor protein (APP) at Thr668, in okadaic acid-induced neurodegeneration
Ahn, Ji-Hwan; So, Sang-Pil; Kim, Na-Young; Kim, Hyun-Ju; Yoon, Seung-Yong; Kim, Dong-Hou;
  PDF(new window)
Several lines of evidence have revealed that phosphorylation of amyloid precursor protein (APP) at Thr668 is involved in the pathogenesis of Alzheimer`s disease (AD). Okadaic acid (OA), a protein phosphatase-2A inhibitor, has been used in AD research models to increase tau phosphorylation and induce neuronal death. We previously showed that OA increased levels of APP and induced accumulation of APP in axonal swellings. In this study, we found that in OA-treated neurons, phosphorylation of APP at Thr668 increased and accumulated in axonal swellings by c-jun N-terminal kinase (JNK), and not by Cdk5 or ERK/MAPK. These results suggest that JNK may be one of therapeutic targets for the treatment of AD.
Alzheimer`s disease;APP;JNK;Okadaic acid;PP2A;
 Cited by
Inhibition of c-Jun N-Terminal Kinase Protects Against Brain Damage and Improves Learning and Memory After Traumatic Brain Injury in Adult Mice, Cerebral Cortex, 2017, 1  crossref(new windwow)
p75 neurotrophin receptor interacts with and promotes BACE1 localization in endosomes aggravating amyloidogenesis, Journal of Neurochemistry, 2017  crossref(new windwow)
Gomez-Isla T, Hollister R, West H et al (1997) Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol 41, 17-24 crossref(new window)

Hardy J and Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356 crossref(new window)

Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM and Binder LI (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 83, 4913-4917 crossref(new window)

Tanimukai H, Grundke-Iqbal I and Iqbal K (2005) Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease. Am J Pathol 166, 1761-1771 crossref(new window)

Tachibana K, Scheuer PJ, Tsukitani Y et al (1981) Okadaic acid, a cytotoxic polyether from two marine sponges of the genus Halichondria. J Am Chem Soc 103, 2469-2471 crossref(new window)

Arias C, Sharma N, Davies P and Shafit-Zagardo B (1993) Okadaic acid induces early changes in microtubuleassociated protein 2 and tau phosphorylation prior to neurodegeneration in cultured cortical neurons. J Neurochem 61, 673-682 crossref(new window)

Sun L, Liu SY, Zhou XW et al (2003) Inhibition of protein phosphatase 2A- and protein phosphatase 1-induced tau hyperphosphorylation and impairment of spatial memory retention in rats. Neuroscience 118, 1175-1182 crossref(new window)

Kamat PK, Rai S and Nath C (2013) Okadaic acid induced neurotoxicity: an emerging tool to study Alzheimer's disease pathology. Neurotoxicology 37, 163-172 crossref(new window)

Wang Z, Yang L and Zheng H (2012) Role of APP and Abeta in synaptic physiology. Curr Alzheimer Res 9, 217-226 crossref(new window)

Lee MS, Kao SC, Lemere CA et al (2003) APP processing is regulated by cytoplasmic phosphorylation. J Cell Biol 163, 83-95 crossref(new window)

Sano Y, Nakaya T, Pedrini S et al (2006) Physiological mouse brain Abeta levels are not related to the phosphorylation state of threonine-668 of Alzheimer's APP. PLoS ONE 1, e51 crossref(new window)

Iijima K, Ando K, Takeda S et al (2000) Neuron-specific phosphorylation of Alzheimer's beta-amyloid precursor protein by cyclin-dependent kinase 5. J Neurochem 75, 1085-1091 crossref(new window)

Liu F, Su Y, Li B et al (2003) Regulation of amyloid precursor protein (APP) phosphorylation and processing by p35/Cdk5 and p25/Cdk5. FEBS Lett 547, 193-196 crossref(new window)

Rockenstein E, Torrance M, Adame A et al(2007) Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation. J Neurosci 27, 1981-1991 crossref(new window)

Muresan Z and Muresan V (2005) c-Jun NH2-terminal kinase-interacting protein-3 facilitates phosphorylation and controls localization of amyloid-beta precursor protein. J Neurosci 25, 3741-3751 crossref(new window)

Dickens M, Rogers JS, Cavanagh J et al (1997) A cytoplasmic inhibitor of the JNK signal transduction pathway. Science 277, 693-696 crossref(new window)

Yoon SY, Choi JE, Yoon JH, Huh JW and Kim DH (2006) BACE inhibitor reduces APP-beta-C-terminal fragment accumulation in axonal swellings of okadaic acid-induced neurodegeneration. Neurobiol Dis 22, 435-444 crossref(new window)

Yoon S, Choi J, Yoon J, Huh JW and Kim D (2006) Okadaic acid induces JNK activation, bim overexpression and mitochondrial dysfunction in cultured rat cortical neurons. Neurosci Lett 394, 190-195 crossref(new window)

Inomata H, Nakamura Y, Hayakawa A et al (2003) A scaffold protein JIP-1b enhances amyloid precursor protein phosphorylation by JNK and its association with kinesin light chain 1. J Biol Chem 278, 22946-22955 crossref(new window)

Bennett BL, Sasaki DT, Murray BW et al (2001) SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci U S A 98, 13681-13686 crossref(new window)

Jiang S, Li Y, Zhang X, Bu G, Xu H and Zhang YW (2014) Trafficking regulation of proteins in Alzheimer's disease. Mol Neurodegener 9, 6 crossref(new window)

Kang J, Lemaire HG, Unterbeck A et al (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733-736 crossref(new window)

Suzuki T and Nakaya T (2008) Regulation of amyloid beta-protein precursor by phosphorylation and protein interactions. J Biol Chem 283, 29633-29637 crossref(new window)

Pastorino L, Sun A, Lu PJ et al (2006) The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production. Nature 440, 528-534 crossref(new window)

Feyt C, Pierrot N, Tasiaux B et al (2007) Phosphorylation of APP695 at Thr668 decreases gamma-cleavage and extracellular Abeta. Biochem Biophys Res Commun 357, 1004-1010 crossref(new window)

Whitmarsh AJ (2006) The JIP family of MAPK scaffold proteins. Biochem Soc Trans 34, 828-832 crossref(new window)

Abe N, Almenar-Queralt A, Lillo C et al (2009) Sunday driver interacts with two distinct classes of axonal organelles. J Biol Chem 284, 34628-34639 crossref(new window)

Cho K, Cho MH, Seo JH et al (2015) Calpain-mediated cleavage of DARPP-32 in Alzheimer's disease. Aging Cell 14, 878-886 crossref(new window)

Song HL, Shim S, Kim DH et al (2014) beta-Amyloid is transmitted via neuronal connections along axonal membranes. Ann Neurol 75, 88-97 crossref(new window)

Park JS, Kim DH and Yoon SY (2016) Regulation of amyloid precursor protein processing by its KFERQ motif. BMB Rep [Epub ahead of print]

Lee JH, Kim IW, Kim SH et al (2015) Anticancer activity of CopA3 dimer peptide in human gastric cancer cells. BMB Rep 48, 324-329 crossref(new window)